Buyers of the provider of critical communications software have been more aggressive for months now, but we may see a correction near term.
EBS has been in an uptrend for a long time.
Technical analysis and trading strategy on the healthcare stock
The charts of CVS are in good shape, so expect renewed strength in the weeks ahead.
I don't see clear signs of aggressive buying.
Robots can't catch Covid-19, or anything else. While the rest of us stay home, they can keep factory output going with a minimum of human intervention.
Quotient Limited and Redhill Biopharma could deliver for shareholders, while Novavax Inc. and Inovio Pharmaceuticals may not in the end.
Sri Trang Gloves, a subsidiary of the world's largest producer of natural rubber, is in the process of getting its initial public offering off the ground in Bangkok.
It is worth tracking these three names.
These companies have the potential to help in battling the Covid-19 pandemic.